Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Eventsin Nonsleepy Patients With Obstructive Sleep Apnea
Barceló Bennasar, Antònia
Masa, Juan F.
Marín, J. M.
García Río, Francisco
Díaz de Atauri, María Josefa
Mayós Pérez, Mercè
Peña, Mónica de la
Campo, Félix del
MetadataShow full item record
Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with sleep-disordered breathing, regardless of daytime symptoms, is unclear. Objective To evaluate the effect of CPAP treatment on the incidence of hypertension or cardiovascular events in a cohort of nonsleepy patients with OSA. Design, Setting, and Patients Multicenter, parallel-group, randomized controlled trial in 14 teaching hospitals in Spain. Between May 2004 and May 2006, 725 consecutive patients were enrolled who had an apnea-hypopnea index of 20 h−1 or greater and an Epworth Sleepiness Scale score of 10 or less (scores range from 0-24, with values 10 suggesting no daytime sleepiness). Exclusion criteria were previous cardiovascular event, physical or psychological incapacity, chronic disease, or drug or alcohol addiction. Follow-up ended in May 2009. Intervention Patients were allocated to receive CPAP treatment or no active intervention. All participants received dietary counseling and sleep hygiene advice. Main Outcome Measures Incidence of either systemic hypertension (taking antihypertensive medication or blood pressure greater than 140/90 mm Hg) or cardiovascular event (nonfatal myocardial infarction, nonfatal stroke, transient ischemic attack, hospitalization for unstable angina or arrhythmia, heart failure, or cardiovascular death). Results Seven hundred twenty-three patients underwent follow-up for a median of 4 (interquartile range, 2.7-4.4) years (1 patient from each group did not receive allocated treatment); 357 in the CPAP group and 366 in the control group were included in the analysis. In the CPAP group there were 68 patients with new hypertension and 28 cardiovascular events (17 unstable angina or arrhythmia, 3 nonfatal stroke, 3 heart failure, 2 nonfatal myocardial infarction, 2 transient ischemic attack, 1 cardiovascular death). In the control group there were 79 patients with new hypertension and 31 cardiovascular events (11 unstable angina or arrhythmia, 8 nonfatal myocardial infarction, 5 transient ischemic attack, 5 heart failure, 2 nonfatal stroke). The hypertension or cardiovascular event incidence density rate was 9.20 per 100 person-years (95% CI, 7.36-11.04) in the CPAP group and 11.02 per 100 person-years (95% CI, 8.96-13.08) in the control group. The incidence density ratio was 0.83 (95% CI, 0.63-1.1; P=.20). Conclusions In patients with OSA without daytime sleepiness, the prescription of CPAP compared with usual care did not result in a statistically significant reduction in the incidence of hypertension or cardiovascular events. However, the study may have had limited power to detect a significant difference.
Is part ofJAMA, 2013, vol. 307, núm. 20, p.2161-2168
European research projects
Showing items related by title, author, creator and subject.
Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial Martínez-García, Miguel Angel; Capote, Francisco; Campos-Rodríguez, Francisco; Lloberes, Patricia; Díaz de Atauri, María Josefa; Somoza, María; Masa, Juan F.; González, Mónica; Sacristán, Lirios; Barbé Illa, Ferran; Durán-Cantolla, Joaquín; Aizpuru, Felipe; Mañas, Eva; Barreiro, Bienvenido; Mosteiro, Mar; Cebrián, Juan J.; Peña, Mónica de la; García-Río, Francisco; Maimó, Andrés; Zapater, Jordi; Hernández, Concepción; Grau Sanmartí, Núria; Montserrat i Capdevila, Josep (American Medical Association, 2013)Importance: More than 70% of patients with resistant hypertension have obstructive sleep apnea (OSA). However, there is little evidence about the effect of continuous positive airway pressure (CPAP) treatment on blood ...
Effect of obstructive sleep apnoea on severity and short-term prognosis of acute coronary syndrome Barbé Illa, Ferran; Sánchez de la Torre, Alicia; Abad, Jorge; Durán-Cantolla, Joaquín; Mediano, Olga; Amilibia, Jose; Masdeu, María José; Florés, Marina; Barceló Bennasar, Antònia; Peña, Mónica de la; Aldomá, Albina; Worner, Fernando; Valls Marsal, Joan; Castellà, Gerard; Sánchez de la Torre, Manuel (European Respiratory Society, 2015)The goal of this study was to evaluate the influence of obstructive sleep apnoea on the severity and short-term prognosis of patients admitted for acute coronary syndrome. Obstructive sleep apnoea was defined as an ...
Impact of obstructive sleep apnea on the levels of placental growth factor (PlGF) and their value for predicting short-term adverse outcomes in patients with acute coronary syndrome Barceló Bennasar, Antònia; Bauçà, Josep Miquel; Yañez, Aina; Fueyo, Laura; Gomez, Cristina; Peña, Mónica de la; Pierola, Javier; Rodriguez, Alberto; Sánchez de la Torre, Manuel; Abad, Jorge; Mediano, Olga; Amilibia, Jose; Masdeu, María José; Terán, Joaquin; Montserrat i Capdevila, Josep; Mayos, Mercè; Sánchez de la Torre, Alicia; Barbé Illa, Ferran (Public Library of Science, 2016)Background Placental growth factor (PlGF) induces angiogenesis and promotes tissue repair, and plasma PlGF levels change markedly during acute myocardial infarction (AMI). Currently, the impact of obstructive sleep apnea ...